Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 4,042 | 3,649 | 4,854 | 6,677 | 7,299 |
| Operating Income | -4,042 | -3,649 | -4,854 | -6,677 | -7,299 |
| Other Income | 0 | 4 | 15 | 51 | 50 |
| Pre-tax Income | -4,042 | -3,645 | -4,839 | -6,626 | -7,249 |
| Net Income Continuous | -4,042 | -3,645 | -4,839 | -6,626 | -7,249 |
| Net Income | $-4,042 | $-3,645 | $-4,839 | $-6,626 | $-7,249 |
| EPS Basic Total Ops | -0.06 | -0.06 | -0.07 | -0.09 | -0.12 |
| EPS Basic Continuous Ops | -0.06 | -0.06 | -0.07 | -0.10 | -0.12 |
| EPS Diluted Total Ops | -0.06 | -0.06 | -0.07 | -0.09 | -0.12 |
| EPS Diluted Continuous Ops | -0.06 | -0.06 | -0.07 | -0.10 | -0.12 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.06 | -0.07 | -0.10 | -0.12 |
| EBITDA(a) | $-4,042 | $-3,646 | $-4,838 | $-6,661 | $-7,282 |